NCT00414648 2023-11-02
MILES
University of Cincinnati
Phase 3 Completed
Clinical Trials
8 trialsNCT00406393 2023-01-04
BMT CTN 0402
Medical College of Wisconsin
Phase 3 Completed
NCT01231412 2019-10-24
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
Fred Hutchinson Cancer Center
Phase 3 Completed
NCT00382109 2019-08-07
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Children's Oncology Group
Phase 3 Completed
NCT00928018 2019-02-01
Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
Dana-Farber Cancer Institute
Phase 3 Completed
NCT03140449 2017-05-04
Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis
National Taiwan University Hospital
Phase 3 Completed
NCT00355862 2014-07-30
Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
University of Regensburg
Phase 3 Completed
NCT00928798 2012-03-08
Topical Rapamycin for Fibrofolliculomas
Maastricht University Medical Center
Phase 3 Completed